Germany-wide personalised medicine study for high-risk paediatric cancer patients.
Comprehensive sequencing and analysis is feasible in clinically relevant time frame.
Half of patients across entities harbored a reasonable confidence druggable target.
Cases of clinical response to targeted agents demonstrate proof of principle.
This model can expand paediatric access to molecular profiling and targeted therapies.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址:北京市海淀区学院路29号 邮编:100083 电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700 |